Integrin signaling in malignant melanoma Silke KuphalRichard BauerAnja-Katrin Bosserhoff OriginalPaper Pages: 195 - 222
Activated leukocyte cell adhesion molecule (ALCAM/CD166): Signaling at the divide of melanoma cell clustering and cell migration? Guido W. M. SwartPim C. LunterLeon C. L. T. van Kempen OriginalPaper Pages: 223 - 236
A Wnt-er Wonderland—The complexity of Wnt signaling in melanoma Ashani T. Weeraratna OriginalPaper Pages: 237 - 250
Bone morphogenetic proteins in melanoma: Angel or devil? Mei-Yu HsuSherry RovinskyDesiRae Muirhead OriginalPaper Pages: 251 - 263
SKI pathways inducing progression of human melanoma Jon A. ReedQiushi LinEstela E. Medrano OriginalPaper Pages: 265 - 272
Functional and therapeutic significance of Akt deregulation in malignant melanoma Gavin P. Robertson OriginalPaper Pages: 273 - 285
Targeting STAT3 affects melanoma on multiple fronts Marcin KortylewskiRichard JoveHua Yu OriginalPaper Pages: 315 - 327
De-regulation of ubiquitin-dependent proteolysis and the pathogenesis of malignant melanoma Serge Y. Fuchs OriginalPaper Pages: 329 - 338
Immunological detection of altered signaling molecules involved in melanoma development Yutaka KawakamiHidetoshi SumimotoYuriko Matsuzaki OriginalPaper Pages: 357 - 366
Erratum, The role of B-RAF in melanoma Vanessa C. Gray-SchopferSilvy da Rocha DiasRichard Marais OriginalPaper Pages: 367 - 367